Replication of the LEADER Diabetes Trial in Healthcare Claims

NCT03936049 · clinicaltrials.gov ↗

COMPLETED

Status

168690

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Liraglutide
DRUG: DPP-4 inhibitor

Sponsor

Brigham and Women's Hospital